Equity · Healthcare
ESPR
NASDAQEsperion Therapeutics, Inc.
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for ESPR to draw a line in its place.
as of Jul 10, 2026
ESPR insider trades
ESPR has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 13 July 2026.
Showing the 12 most recent of 14 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 18 compensation filings in this window. The figures above count all of them.
ESPR earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
ESPR institutional holders
SEC EDGAR8 of the 45 institutional funds we track reported a ESPR position for the quarter ended 30 Jun 2026 — a combined $49.2M; the latest of those filings landed 02 Sep 2026.
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR 13F filings
- SEC EDGARValuation computed from SEC EDGAR filings
- Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Esperion_Therapeutics